Princeton University President Christopher L. Eisgruber speaks with Irina Aranovich, general supervisor of Princeton’s Diagnostic Laboratory, on a tour of the campus’ new COVID-19 testing facility.
When Alexander Ploss’ team discovered a compound that blocks the cancer-causing hepatitis B virus, he knew that such findings require additional research before they are ready for testing in patients. Ploss turned to the Science Center, a Philadelphia-based organization.
